Tolerx

Monoclonal antibody for the treatment of autoimmune type 1 diabetes

placeCambridge, Massachusetts, United States calendar_todayFounded 2000 groups13 employees language tolerx.com

Innovation

18 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace dormant. Cited 832 times.

YearFilings
20125
20134
20141
20181

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon